Literature DB >> 20171505

Radiation dose-volume effects of the urinary bladder.

Akila N Viswanathan1, Ellen D Yorke, Lawrence B Marks, Patricia J Eifel, William U Shipley.   

Abstract

An in-depth overview of the normal-tissue radiation tolerance of the urinary bladder is presented. The most informative studies consider whole-organ irradiation. The data on partial-organ/nonuniform irradiation are suspect because the bladder motion is not accounted for, and many studies lack long enough follow-up data. Future studies are needed. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20171505      PMCID： PMC3587780          DOI： 10.1016/j.ijrobp.2009.02.090

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  53 in total

1.  Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.

Authors:  C Fellner; R Pötter; T H Knocke; A Wambersie
Journal:  Radiother Oncol       Date:  2001-01       Impact factor: 6.280

2.  Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer.

Authors:  B G Gardner; A L Zietman; W U Shipley; U E Skowronski; P McManus
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

3.  Urinary tract dysfunction after radical hysterectomy for cervical cancer.

Authors:  Gin-Den Chen; Long-Yau Lin; Po-Hui Wang; Hong-Shen Lee
Journal:  Gynecol Oncol       Date:  2002-05       Impact factor: 5.482

4.  Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer.

Authors:  Patricia J Eifel; Anuja Jhingran; Diane C Bodurka; Charles Levenback; Howard Thames
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

5.  Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

Authors:  W U Shipley; D S Kaufman; E Zehr; N M Heney; S C Lane; H K Thakral; A F Althausen; A L Zietman
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

6.  Concomitant boost radiotherapy for muscle invasive bladder cancer.

Authors:  Floris J Pos; Geertjan van Tienhoven; Maarten C C M Hulshof; Kees Koedooder; Dionisio González González
Journal:  Radiother Oncol       Date:  2003-07       Impact factor: 6.280

7.  Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.

Authors:  A Aydin Yavuz; Melek N Yavuz; Guner K Ozgur; Fatma Colak; Rasin Ozyavuz; Emel Cimsitoglu; Esra Ilis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

8.  Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

Authors:  Abrahim Al-Mamgani; Wim L J van Putten; Wilma D Heemsbergen; Geert J L H van Leenders; Annerie Slot; Michel F H Dielwart; Luca Incrocci; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

9.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Authors:  Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

10.  Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer.

Authors:  Ludvig Paul Muren; Rune Smaaland; Olav Dahl
Journal:  Radiother Oncol       Date:  2003-12       Impact factor: 6.280
View more
  106 in total

1.  Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning.

Authors:  T Long; M Matuszak; M Feng; B A Fraass; R K Ten Haken; H E Romeijn
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

Review 2.  Image-guided radiation therapy for muscle-invasive bladder cancer.

Authors:  Juliette Thariat; Shafak Aluwini; Qiong Pan; Mickael Caullery; Pierre-Yves Marcy; Martin Housset; Jean-Leon Lagrange
Journal:  Nat Rev Urol       Date:  2011-11-08       Impact factor: 14.432

3.  Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.

Authors:  Justin E Bekelman; Nandita Mitra; Jason Efstathiou; Kaijun Liao; Robert Sunderland; Deborah N Yeboa; Katrina Armstrong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-16       Impact factor: 7.038

4.  A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma : Comparison of 3‑dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy.

Authors:  Sergiu Scobioala; Christopher Kittel; Philipp Niermann; Heidi Wolters; Katharina Helene Susek; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2018-05-31       Impact factor: 3.621

5.  CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm.

Authors:  Shayan Mostafaei; Hamid Abdollahi; Shiva Kazempour Dehkordi; Isaac Shiri; Abolfazl Razzaghdoust; Seyed Hamid Zoljalali Moghaddam; Afshin Saadipoor; Fereshteh Koosha; Susan Cheraghi; Seied Rabi Mahdavi
Journal:  Radiol Med       Date:  2019-09-24       Impact factor: 3.469

6.  The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies.

Authors:  M Hussein; S Aldridge; T Guerrero Urbano; A Nisbet
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

7.  Evaluating the Role of Urinalysis for Suspected Cystitis in Women Undergoing Pelvic Radiotherapy.

Authors:  Rebecca Anne Shuford; Caleb R Dulaney; Omer L Burnett; Kevin W Byram; Andrew M McDonald
Journal:  Int J Gynecol Cancer       Date:  2016-04-21       Impact factor: 3.437

8.  Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.

Authors:  Kevin L Moore; Rachel Schmidt; Vitali Moiseenko; Lindsey A Olsen; Jun Tan; Ying Xiao; James Galvin; Stephanie Pugh; Michael J Seider; Adam P Dicker; Walter Bosch; Jeff Michalski; Sasa Mutic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-03       Impact factor: 7.038

Review 9.  Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: an MRI based approach.

Authors:  Tejinder Kataria; Deepak Gupta; Shikha Goyal; Shyam S Bisht; Ravi Chaudhary; Kushal Narang; Susovan Banerjee; Trinanjan Basu; Ashu Abhishek; Sasikumar Sambasivam; Nisha T Vishnu
Journal:  Br J Radiol       Date:  2016-10-17       Impact factor: 3.039

10.  Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.

Authors:  Kentaro Ishii; Ryo Ogino; Yukinari Hosokawa; Chiaki Fujioka; Wataru Okada; Ryota Nakahara; Ryu Kawamorita; Takuhito Tada; Yoshiki Hayashi; Toshifumi Nakajima
Journal:  Br J Radiol       Date:  2016-03-31       Impact factor: 3.039
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.